MoneyWorks4Me

Hester Biosciences board to consider Unaudited Financial Results

13 Jul 2015 Evaluate

Hester Biosciences has informed that meeting of the Board of Directors of the Company will be held on July 22, 2015, to consider and approve the Unaudited Financial Results for the quarter ended on June 30, 2015. Also in accordance with the applicable regulations of Insider Trading Regulations, the ‘Trading Window’ for dealing in equity shares of the Company shall remain closed from July 14, 2015 to July 24, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1213.00
Cipla 1373.35
Lupin 2093.60
Zydus Lifesciences 1161.25
View more..